Distribution and prognostic value of macrophages in colorectal cancer and adjacent mucosa in patient stages I-III <i>vs</i> IV
Contrary to TC of pCRC, we found favorable prognostic implications of macrophages in NM, driven by distinct subsets of macrophages in stage IV (CD163+ M2) and stage I-III CRC (CD80+ M1).
Authors
- Ondřej Vyčítal (ORCID: https://orcid.org/0000-0001-7531-9751)
- Andriy Trailin (ORCID: https://orcid.org/0000-0001-8888-0759)
- Lenka Červenková (ORCID: https://orcid.org/0000-0001-7251-210X)
- Wenjing Ye (ORCID: https://orcid.org/0000-0002-2764-9649)
- Esraa Ali (ORCID: https://orcid.org/0000-0001-8962-2516)
- Ondřej Daum (ORCID: https://orcid.org/0000-0002-0930-7071)
- František Zitrický
- Filip Ambrozkiewicz
- Kari Hemminki
- Sergii Pavlov
- Petr Hošek
- Václav Liška
Institutions
- Technical University of Liberec (CZ)
- German Cancer Research Center (DE)
- Charles University (CZ)
- Heidelberg University (DE)
- Pilsen Tools (Czechia) (CZ)
- Krajská Nemocnice Liberec (CZ)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.3748/wjg.v32.i10.115130
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00